University of Texas Health Science Center at Houston Endocrinology, Diabetes, and Metabolism

Topics

• Adrenal and Paraganglionic Tumors 20
• Thyroid Cancer Diagnosis and Treatment 14
• Pituitary Gland Disorders and Treatments 9
• Diabetes Treatment and Management 8
• Adipokines, Inflammation, and Metabolic Diseases 6
• Diabetes and associated disorders 5
• Diabetes Management and Research 4
• Genetic Neurodegenerative Diseases 4
• Health Policy Implementation Science 4
• Parathyroid Disorders and Treatments 4
• Adrenal Hormones and Disorders 3
• Bone health and treatments 3

Most cited

1. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.

   The New England journal of medicine · 2022 · 158 citations · Luz Castellanos

2. Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial.

   The Lancet. Oncology · 2024 · 34 citations · Jeena Varghese

3. Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.

   The Lancet. Oncology · 2024 · 27 citations · Jeena Varghese

4. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.

   The Journal of clinical endocrinology and metabolism · 2023 · 32 citations · Jeena Varghese

5. Lifestyle Intervention Strategy to Treat Diabetes in Older Adults: A Randomized Controlled Trial.

   Diabetes care · 2022 · 51 citations · Dean Blevins

6. Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab.

   JCO oncology practice · 2025 · 16 citations · Sonya Khan